JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
14.12%
↑ 402% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
2.81%
Historical baseline
PeriodValue
202514.12%
20243.99%
2023-22.71%
2022-1.92%
20210.03%
2020-26.46%
201918.17%
201816.63%
20174.81%
201621.46%